| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH2 MYH6 ABCC4 ABCA12 TMEM94 DDX5 SLC27A1 KIF28P CHD6 DNAH8 DNAH9 DYNC1H1 KIF11 ACSS3 PMS1 ATP13A4 UBA2 CHD8 KIF20B DNAH1 SMARCA4 ABCB11 ATP4A ACSL5 | 6.95e-06 | 614 | 281 | 24 | GO:0140657 |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 8.48e-06 | 73 | 281 | 8 | GO:0170055 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 4.01e-05 | 28 | 281 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCC4 ABCA12 LRRK2 DDX5 KIF28P GNA11 CHD6 GNAQ DNAH8 DNAH9 DYNC1H1 AGAP2 PMS1 EEFSEC ATP13A4 RAB17 CHD8 SAR1A KIF20B ARL4D ARL4C SAR1B SMARCA4 ABCB11 RASEF ATP4A | 4.06e-05 | 775 | 281 | 26 | GO:0017111 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.47e-05 | 118 | 281 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 5.70e-05 | 70 | 281 | 7 | GO:0003777 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.01e-04 | 18 | 281 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.06e-04 | 34 | 281 | 5 | GO:0015125 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCC4 ABCA12 LRRK2 DDX5 KIF28P GNA11 CHD6 GNAQ DNAH8 DNAH9 DYNC1H1 AGAP2 PMS1 EEFSEC ATP13A4 RAB17 CHD8 SAR1A KIF20B ARL4D ARL4C SAR1B SMARCA4 ABCB11 RASEF ATP4A | 1.47e-04 | 839 | 281 | 26 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCC4 ABCA12 LRRK2 DDX5 KIF28P GNA11 CHD6 GNAQ DNAH8 DNAH9 DYNC1H1 AGAP2 PMS1 EEFSEC ATP13A4 RAB17 CHD8 SAR1A KIF20B ARL4D ARL4C SAR1B SMARCA4 ABCB11 RASEF ATP4A | 1.50e-04 | 840 | 281 | 26 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCC4 ABCA12 LRRK2 DDX5 KIF28P GNA11 CHD6 GNAQ DNAH8 DNAH9 DYNC1H1 AGAP2 PMS1 EEFSEC ATP13A4 RAB17 CHD8 SAR1A KIF20B ARL4D ARL4C SAR1B SMARCA4 ABCB11 RASEF ATP4A | 1.50e-04 | 840 | 281 | 26 | GO:0016818 |
| GeneOntologyMolecularFunction | amino acid sensor activity | 1.97e-04 | 2 | 281 | 2 | GO:0140785 | |
| GeneOntologyMolecularFunction | ATPase-coupled lipid transmembrane transporter activity | 2.18e-04 | 9 | 281 | 3 | GO:0034040 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DAB2IP TRIO LRRK2 ANKRD27 DENND10 NF1 DENND6B GNAQ SEC23B SEC23A ARAP1 AGAP2 DOCK9 RALGPS2 PSD3 PREX2 CCDC88A RAB3IP | 3.26e-04 | 507 | 281 | 18 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DAB2IP TRIO LRRK2 ANKRD27 DENND10 NF1 DENND6B GNAQ SEC23B SEC23A ARAP1 AGAP2 DOCK9 RALGPS2 PSD3 PREX2 CCDC88A RAB3IP | 3.26e-04 | 507 | 281 | 18 | GO:0030695 |
| GeneOntologyMolecularFunction | lipid transporter activity | ABCC4 PSG1 PSG4 ABCA12 SLC27A1 OSBPL8 STARD3 PSG8 SLCO2A1 ABCB11 | 4.78e-04 | 196 | 281 | 10 | GO:0005319 |
| GeneOntologyMolecularFunction | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity | 5.87e-04 | 3 | 281 | 2 | GO:0003976 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 6.91e-04 | 29 | 281 | 4 | GO:0035325 | |
| GeneOntologyMolecularFunction | filamin binding | 6.91e-04 | 29 | 281 | 4 | GO:0031005 | |
| GeneOntologyMolecularFunction | lipid binding | DAB2IP IRX5 FRMPD4 ACADVL PSG1 PSG4 GAB2 SNX13 RPS6KC1 RBP7 NF1 SPON2 OSBPL8 STARD3 PLA2G2A PDZD8 PSG8 HSD17B1 ANXA9 BAIAP3 ARAP1 VDAC1 CPNE5 CCDC88A IGF2R PPT1 OSBPL3 | 7.87e-04 | 988 | 281 | 27 | GO:0008289 |
| GeneOntologyMolecularFunction | phospholipid binding | DAB2IP FRMPD4 PSG1 PSG4 GAB2 SNX13 RPS6KC1 NF1 OSBPL8 PLA2G2A PSG8 ANXA9 BAIAP3 ARAP1 VDAC1 CPNE5 CCDC88A PPT1 | 8.08e-04 | 548 | 281 | 18 | GO:0005543 |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 8.95e-04 | 14 | 281 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | ABC-type bile acid transporter activity | 1.16e-03 | 4 | 281 | 2 | GO:0015432 | |
| GeneOntologyMolecularFunction | oleoyl-CoA ligase activity | 1.16e-03 | 4 | 281 | 2 | GO:0090434 | |
| GeneOntologyMolecularFunction | ATPase-coupled organic acid transmembrane transporter activity | 1.16e-03 | 4 | 281 | 2 | GO:0033283 | |
| GeneOntologyMolecularFunction | ATPase-coupled monocarboxylic acid transmembrane transporter activity | 1.16e-03 | 4 | 281 | 2 | GO:0033285 | |
| GeneOntologyMolecularFunction | ATPase-coupled carboxylic acid transmembrane transporter activity | 1.16e-03 | 4 | 281 | 2 | GO:0033284 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC4 ABCA12 DDX5 KIF28P CHD6 DNAH8 DNAH9 DYNC1H1 PMS1 ATP13A4 CHD8 KIF20B SMARCA4 ABCB11 ATP4A | 1.55e-03 | 441 | 281 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | calmodulin binding | 1.62e-03 | 230 | 281 | 10 | GO:0005516 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | TRIO ANKRD27 DENND10 DENND6B DOCK9 RALGPS2 PSD3 PREX2 CCDC88A RAB3IP | 1.67e-03 | 231 | 281 | 10 | GO:0005085 |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.71e-03 | 90 | 281 | 6 | GO:0008028 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.76e-03 | 37 | 281 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | alkylglycerophosphoethanolamine phosphodiesterase activity | 1.92e-03 | 5 | 281 | 2 | GO:0047391 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PSG1 PSG4 CDH23 TENM2 FAT1 FAT2 PTPRD CNTN5 PSG8 SDK1 VCAM1 SDK2 FAT3 NTNG1 PCDHA6 TENM3 | 6.78e-06 | 313 | 281 | 16 | GO:0098742 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | TMEM67 MYH6 IL18 IRX5 PSG1 PSG4 ABCA12 LRRK2 CDH23 MECOM ITGA2 PLXND1 PHEX HOXB8 FAT1 GRXCR2 NF1 PTPRQ NTN1 PSG8 MMP2 ALDH1A3 SDK1 COL6A1 SDK2 FAT3 WNT9A MUC19 NTNG1 TENM3 LRIG1 XIRP2 HS2ST1 SMARCA4 SMARCC1 HAS2 IRX2 | 1.03e-05 | 1269 | 281 | 37 | GO:0009887 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PSG1 PSG4 CDH23 FAT1 FAT2 CNTN5 PSG8 SDK1 SDK2 FAT3 PCDHA6 TENM3 | 1.04e-05 | 187 | 281 | 12 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | BOC IL18 ABL2 PSG1 PSG4 ABCA12 CDH23 ITGA2 TENM2 SVEP1 FAT1 FAT2 PTPRD CNTN5 PLA2G2A NTN1 PSG8 ANXA9 SDK1 AP3D1 VCAM1 ZC3H12A SDK2 FAT3 NTNG1 PCDHA6 ST3GAL4 ZAP70 TENM3 SMARCA4 CD58 SMARCC1 HAS2 | 1.19e-05 | 1077 | 281 | 33 | GO:0098609 |
| GeneOntologyCellularComponent | glutamatergic synapse | TANC2 ABL2 FRMPD4 TRIO LRRK2 PLXND1 ERBIN TENM2 NF1 GRID2IP PTPRD SV2A SCN2A NTN1 CACNA1H NOS1 AP3D1 AGAP2 BEGAIN RAB17 PSD3 NTNG1 GRIN2C TENM3 NETO2 PLXNA4 GABBR1 | 1.92e-05 | 817 | 283 | 27 | GO:0098978 |
| GeneOntologyCellularComponent | COPII vesicle coat | 5.26e-05 | 16 | 283 | 4 | GO:0030127 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | TMEM67 RPN1 TMEM94 PSKH1 SPCS2 LRRK2 TRDN DNAJB14 PARP6 SLC27A1 OSBPL8 STARD3 PLA2G2A PDZD8 GRIN3B OR7A17 OR7A10 NOS1 SEC23B SEC23A ATP13A4 ZC3H12A RHBDF2 TMEM43 GRIN2C ERN2 SAR1A BCAP31 STS OSBPL3 SAR1B HAS2 GABBR1 ACSL5 | 1.78e-04 | 1299 | 283 | 34 | GO:0098827 |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 2.48e-04 | 42 | 283 | 5 | GO:0070971 | |
| GeneOntologyCellularComponent | lysosome | LRRK2 NCF2 GNPTG ANKRD27 RPS6KC1 STARD3 GCA GNA11 GNAQ NOS1 AP3D1 DYNC1H1 COL6A1 SLC36A4 SAR1A STS PPT1 SLCO2A1 SAR1B RNASET2 AP5M1 HAS2 NBR1 FCMR | 2.98e-04 | 811 | 283 | 24 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | LRRK2 NCF2 GNPTG ANKRD27 RPS6KC1 STARD3 GCA GNA11 GNAQ NOS1 AP3D1 DYNC1H1 COL6A1 SLC36A4 SAR1A STS PPT1 SLCO2A1 SAR1B RNASET2 AP5M1 HAS2 NBR1 FCMR | 2.98e-04 | 811 | 283 | 24 | GO:0000323 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | TMEM67 RPN1 TMEM94 PSKH1 SPCS2 LRRK2 TRDN DNAJB14 SLC27A1 OSBPL8 STARD3 PLA2G2A PDZD8 GRIN3B OR7A17 OR7A10 NOS1 SEC23B SEC23A ATP13A4 ZC3H12A RHBDF2 TMEM43 GRIN2C ERN2 SAR1A BCAP31 STS OSBPL3 SAR1B HAS2 GABBR1 ACSL5 | 3.50e-04 | 1293 | 283 | 33 | GO:0005789 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | TMEM67 RPN1 TMEM94 PSKH1 SPCS2 LRRK2 TRDN DNAJB14 SLC27A1 OSBPL8 STARD3 PLA2G2A PDZD8 GRIN3B OR7A17 OR7A10 NOS1 SEC23B SEC23A ATP13A4 ZC3H12A RHBDF2 TMEM43 GRIN2C ERN2 SAR1A BCAP31 STS OSBPL3 SAR1B HAS2 GABBR1 ACSL5 | 5.51e-04 | 1327 | 283 | 33 | GO:0042175 |
| GeneOntologyCellularComponent | coated membrane | 6.02e-04 | 106 | 283 | 7 | GO:0048475 | |
| GeneOntologyCellularComponent | membrane coat | 6.02e-04 | 106 | 283 | 7 | GO:0030117 | |
| GeneOntologyCellularComponent | presynaptic active zone | 6.85e-04 | 141 | 283 | 8 | GO:0048786 | |
| GeneOntologyCellularComponent | vacuole | LRRK2 NCF2 GNPTG ANKRD27 MEFV RPS6KC1 STARD3 GCA GNA11 GNAQ NOS1 AP3D1 DYNC1H1 COL6A1 SLC36A4 SAR1A STS PPT1 SLCO2A1 SAR1B RNASET2 AP5M1 HAS2 NBR1 FCMR | 6.98e-04 | 913 | 283 | 25 | GO:0005773 |
| GeneOntologyCellularComponent | lamellar body membrane | 1.08e-03 | 4 | 283 | 2 | GO:0097232 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 1.21e-03 | 16 | 283 | 3 | GO:0070021 | |
| Domain | P-loop_NTPase | TANC2 MYH2 MYH6 ABCC4 ABCA12 LRRK2 DDX5 MYO15B GNA11 CHD6 GNAQ DNAH8 DNAH9 DYNC1H1 KIF11 AGAP2 EEFSEC TPST1 RAB17 CHD8 SAR1A KIF20B ARL4D DNAH1 ARL4C HS2ST1 SAR1B SMARCA4 ABCB11 RASEF | 9.81e-06 | 848 | 277 | 30 | IPR027417 |
| Domain | ATPase_dyneun-rel_AAA | 4.22e-05 | 14 | 277 | 4 | IPR011704 | |
| Domain | MT | 4.22e-05 | 14 | 277 | 4 | PF12777 | |
| Domain | AAA_8 | 4.22e-05 | 14 | 277 | 4 | PF12780 | |
| Domain | AAA_5 | 4.22e-05 | 14 | 277 | 4 | PF07728 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.22e-05 | 14 | 277 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.22e-05 | 14 | 277 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.22e-05 | 14 | 277 | 4 | IPR013602 | |
| Domain | DHC_N2 | 4.22e-05 | 14 | 277 | 4 | PF08393 | |
| Domain | IGc2 | BOC TRIO PSG1 PSG4 PTPRD CNTN5 PSG8 SDK1 VCAM1 SDK2 MYOM3 LRIG1 CD22 | 5.19e-05 | 235 | 277 | 13 | SM00408 |
| Domain | Ig_sub2 | BOC TRIO PSG1 PSG4 PTPRD CNTN5 PSG8 SDK1 VCAM1 SDK2 MYOM3 LRIG1 CD22 | 5.19e-05 | 235 | 277 | 13 | IPR003598 |
| Domain | DHC_fam | 5.68e-05 | 15 | 277 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 5.68e-05 | 15 | 277 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 5.68e-05 | 15 | 277 | 4 | IPR004273 | |
| Domain | BRK | 6.24e-05 | 6 | 277 | 3 | SM00592 | |
| Domain | BRK_domain | 6.24e-05 | 6 | 277 | 3 | IPR006576 | |
| Domain | BRK | 6.24e-05 | 6 | 277 | 3 | PF07533 | |
| Domain | ig | 1.31e-04 | 190 | 277 | 11 | PF00047 | |
| Domain | Immunoglobulin | 1.31e-04 | 190 | 277 | 11 | IPR013151 | |
| Domain | DHC_N1 | 1.71e-04 | 8 | 277 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.71e-04 | 8 | 277 | 3 | IPR013594 | |
| Domain | SAR1 | 2.19e-04 | 2 | 277 | 2 | PS51422 | |
| Domain | VCAM-1 | 2.19e-04 | 2 | 277 | 2 | IPR003989 | |
| Domain | Small_GTPase_SAR1 | 2.19e-04 | 2 | 277 | 2 | IPR006687 | |
| Domain | PDZ | 2.59e-04 | 141 | 277 | 9 | PF00595 | |
| Domain | - | ABCC4 ABCA12 LRRK2 DDX5 GNA11 CHD6 GNAQ DNAH8 DNAH9 DYNC1H1 AGAP2 EEFSEC TPST1 RAB17 CHD8 SAR1A ARL4D DNAH1 ARL4C HS2ST1 SAR1B SMARCA4 ABCB11 RASEF | 3.28e-04 | 746 | 277 | 24 | 3.40.50.300 |
| Domain | PDZ | 3.71e-04 | 148 | 277 | 9 | SM00228 | |
| Domain | - | 4.10e-04 | 150 | 277 | 9 | 2.30.42.10 | |
| Domain | PDZ | 4.30e-04 | 151 | 277 | 9 | PS50106 | |
| Domain | PDZ | 4.51e-04 | 152 | 277 | 9 | IPR001478 | |
| Domain | Ig_I-set | 5.60e-04 | 190 | 277 | 10 | IPR013098 | |
| Domain | I-set | 5.60e-04 | 190 | 277 | 10 | PF07679 | |
| Domain | Rhs_assc_core | 6.51e-04 | 3 | 277 | 2 | IPR022385 | |
| Domain | SUZ-C | 6.51e-04 | 3 | 277 | 2 | IPR024642 | |
| Domain | SUZ-C | 6.51e-04 | 3 | 277 | 2 | PF12901 | |
| Domain | VWF_A | 6.82e-04 | 99 | 277 | 7 | IPR002035 | |
| Domain | - | 8.03e-04 | 74 | 277 | 6 | 3.40.50.410 | |
| Domain | Arf | 1.09e-03 | 31 | 277 | 4 | PF00025 | |
| Domain | Tox-GHH_dom | 1.29e-03 | 4 | 277 | 2 | IPR028916 | |
| Domain | ABL9/DENND6_dom | 1.29e-03 | 4 | 277 | 2 | IPR018307 | |
| Domain | Tox-GHH | 1.29e-03 | 4 | 277 | 2 | PF15636 | |
| Domain | Ten_N | 1.29e-03 | 4 | 277 | 2 | PF06484 | |
| Domain | Nebulin_repeat | 1.29e-03 | 4 | 277 | 2 | IPR000900 | |
| Domain | TENEURIN_N | 1.29e-03 | 4 | 277 | 2 | PS51361 | |
| Domain | Nebulin | 1.29e-03 | 4 | 277 | 2 | PF00880 | |
| Domain | NEBULIN | 1.29e-03 | 4 | 277 | 2 | PS51216 | |
| Domain | NEBU | 1.29e-03 | 4 | 277 | 2 | SM00227 | |
| Domain | Avl9 | 1.29e-03 | 4 | 277 | 2 | PF09794 | |
| Domain | Nebulin | 1.29e-03 | 4 | 277 | 2 | IPR013998 | |
| Domain | Ten_N | 1.29e-03 | 4 | 277 | 2 | IPR009471 | |
| Domain | Gprotein_alpha_Q | 1.29e-03 | 4 | 277 | 2 | IPR000654 | |
| Domain | Small_GTPase_ARF/SAR | 1.38e-03 | 33 | 277 | 4 | IPR006689 | |
| Domain | IG | BOC TRIO PSG1 PSG4 PTPRD CNTN5 PSG8 SDK1 VCAM1 SDK2 MYOM3 LRIG1 CD22 CD58 FCMR | 1.63e-03 | 421 | 277 | 15 | SM00409 |
| Domain | Ig_sub | BOC TRIO PSG1 PSG4 PTPRD CNTN5 PSG8 SDK1 VCAM1 SDK2 MYOM3 LRIG1 CD22 CD58 FCMR | 1.63e-03 | 421 | 277 | 15 | IPR003599 |
| Pubmed | DAB2IP FRMPD4 TMEM94 CDK19 ERBIN TENM2 SNX13 CSDE1 SV2A CACNA1H CHD6 BAIAP3 TET3 DYNC1H1 SCAF8 DOCK9 PSD3 HEATR5A NUP214 TENM3 PDZD2 | 3.17e-11 | 407 | 285 | 21 | 12693553 | |
| Pubmed | TPP2 NDUFS1 XAB2 CSDE1 NF1 OSBPL8 PHIP DYNC1H1 SEC23B SEC23A USP47 VDAC1 H1-10 SRSF5 CHD8 NUP214 HUWE1 NIFK NOP58 IGF2R ASNS PES1 SMARCA4 SMARCC1 ATM EPB41L2 | 4.33e-11 | 653 | 285 | 26 | 22586326 | |
| Pubmed | ABCC4 RPN1 ANKRD27 DNAJB14 XAB2 DDX5 NF1 SLC27A1 FEN1 OSBPL8 PDZD8 AP3D1 CNN2 DYNC1H1 KIF11 AGAP2 APMAP DOCK9 ST3GAL4 HUWE1 NCAPH TUBGCP6 NOP58 BCAP31 IGF2R PPT1 OSBPL3 HS2ST1 PES1 SMARCA4 CD58 EIF3H NBR1 ACSL5 | 1.90e-10 | 1168 | 285 | 34 | 19946888 | |
| Pubmed | DAB2IP TANC2 FRMPD4 TRIO ACADVL RPN1 LRP1B ERBIN TENM2 NDUFS1 RPS6KC1 YTHDF1 CSDE1 PSMD6 SAFB NF1 KCNF1 SV2A OSBPL8 STIP1 DCLK2 NOS1 VDAC1 AGAP2 BEGAIN DOCK9 PSD3 TMEM43 HUWE1 CCDC88A CNDP2 EPB41L2 GABBR1 | 4.04e-10 | 1139 | 285 | 33 | 36417873 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRIO RPN1 PSMA3 NDUFS1 DDX5 CDCA2 PSMD6 SAFB NF1 FEN1 STIP1 PHIP DYNC1H1 SEC23A KIF11 VDAC1 H1-10 SRSF5 APMAP NUP214 TMEM43 HUWE1 NCAPH SAR1A NIFK NOP58 BCAP31 PDE12 IGF2R ASNS PES1 SMARCA4 SMARCC1 ATM EIF3H NBR1 EPB41L2 | 6.68e-10 | 1425 | 285 | 37 | 30948266 |
| Pubmed | RPN1 PSMA3 NDUFS1 DDX5 YTHDF1 CSDE1 PSMD6 STIP1 AP3D1 DYNC1H1 SEC23A KIF11 VDAC1 NUP214 HUWE1 NOP58 BCAP31 ASNS PES1 SMARCA4 SMARCC1 EIF3H EPB41L2 | 3.96e-09 | 638 | 285 | 23 | 33239621 | |
| Pubmed | DAB2IP CDK19 ERBIN ZC3H4 OSBPL8 CHD6 BAIAP3 ARAP1 DOCK9 GNPTAB PSD3 CHD8 PCNX1 AKAP11 | 6.19e-09 | 225 | 285 | 14 | 12168954 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | TMEM67 ABCC4 RPN1 SPCS2 ITGA2 PLXND1 GNPTG ZZEF1 LRP1B DNAJB14 CSDE1 FAP FAT1 NF1 MMP2 FKBP10 COL6A1 TPST1 GNPTAB ST3GAL4 TMEM43 BCAP31 IGF2R STS TENM3 PPT1 NETO2 HS2ST1 PES1 CD58 ATM | 2.08e-08 | 1201 | 285 | 31 | 35696571 |
| Pubmed | TANC2 TPP2 MYH6 TRIO RPN1 ITGA2 ERBIN NDUFS1 DDX5 CSDE1 PSMD6 SAFB NF1 SV2A SLC27A1 SCN2A UGP2 OSBPL8 STIP1 DCLK2 GNAQ NOS1 AP3D1 DYNC1H1 SEC23A VDAC1 AGAP2 SRSF5 PSD3 OMG LRIG1 PLXNA4 SMARCA4 EPB41L2 | 3.09e-08 | 1431 | 285 | 34 | 37142655 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ACADVL RPN1 PSMA3 ZZEF1 DDX5 PSMD6 SAFB STIP1 AP3D1 DYNC1H1 SEC23A VDAC1 H1-10 APMAP MUC19 CHD8 HUWE1 SAR1A DNAH1 NOP58 BCAP31 SAR1B CNDP2 PCNX1 | 6.98e-08 | 807 | 285 | 24 | 30575818 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | TANC2 TRIO TMEM94 DDX5 RPS6KC1 PHKA1 SAFB NF1 CHD6 PHIP AP3D1 SCAF8 PSD3 CHD8 NUP214 PREX2 TUBGCP6 MAST3 | 9.75e-08 | 475 | 285 | 18 | 31040226 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PSMA3 ERBIN SAFB NF1 ZC3H4 TAF6 ANXA9 USP47 VDAC1 H1-10 SRSF5 SCAF8 UBA2 NUP214 HUWE1 GTF2IRD1 TUBGCP6 SMARCA4 SENP6 SMARCC1 ATM MAPK8 EPB41L2 | 1.34e-07 | 774 | 285 | 23 | 15302935 |
| Pubmed | LRRK2 PLXND1 ERBIN GAB2 CDCA2 FAT1 ZC3H4 SDK1 AP3D1 DYNC1H1 SEC23B SEC23A HUWE1 NCAPH SAR1A ARL4D ARL4C BCAP31 CCDC88A IGF2R TENM3 SAR1B EPB41L2 | 1.44e-07 | 777 | 285 | 23 | 35844135 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | IL18 RPN1 PSMA3 ERBIN ANKRD27 NDUFS1 DDX5 CDCA2 CSDE1 SAFB NF1 FEN1 PHIP AP3D1 DYNC1H1 SEC23A KIF11 H1-10 CHD8 NUP214 HUWE1 NCAPH KIF20B NIFK NOP58 PDE12 ASNS PES1 SMARCA4 SMARCC1 EPB41L2 | 2.90e-07 | 1353 | 285 | 31 | 29467282 |
| Pubmed | MYH2 MYH6 LARP6 ACADVL RPN1 NEB TRDN ERBIN DNAJB14 NDUFS1 DDX5 RPS6KC1 CDCA2 PHEX SAFB SLC27A1 UGP2 CHD6 DNAH8 AP3D1 KIF11 AGAP2 TMEM43 NCAPH BCAP31 STS PES1 PLXNA4 SMARCC1 IRAK3 ATM FCMR | 3.72e-07 | 1442 | 285 | 32 | 35575683 | |
| Pubmed | DAB2IP TANC2 TPP2 TRIO ERBIN TENM2 NF1 PTPRD ZC3H4 STIP1 NOS1 DYNC1H1 SEC23A KIF11 AGAP2 BEGAIN CHD8 HUWE1 CCDC88A IGF2R OSBPL3 RAB3IP SMARCA4 SMARCC1 EPB41L2 | 4.71e-07 | 963 | 285 | 25 | 28671696 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ACADVL RPN1 ANKRD27 NDUFS1 XAB2 DDX5 CSDE1 SAFB FEN1 OSBPL8 STIP1 CHD6 TAF6 PHIP AP3D1 DYNC1H1 SEC23B H1-10 SCAF8 UBA2 CHD8 NUP214 HUWE1 NCAPH NIFK NOP58 PES1 CNDP2 SMARCA4 SMARCC1 | 5.23e-07 | 1318 | 285 | 30 | 30463901 |
| Pubmed | Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes. | 5.45e-07 | 3 | 285 | 3 | 15744052 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ABCC4 TRIO CDK19 TMEM63B ERBIN CSDE1 NTN1 C1orf159 CACNA1H DCLK2 CHD6 BAIAP3 TET3 ARAP1 ZNF793 RAB17 RHBDF2 SCAF8 APMAP E2F3 HUWE1 GTF2IRD1 DNAH1 ZBTB46 HS2ST1 RAB3IP CNDP2 RASEF GREB1 PATJ NBR1 PDZD2 | 7.45e-07 | 1489 | 285 | 32 | 28611215 |
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 8.70e-07 | 91 | 285 | 8 | 28558017 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | RPN1 ZZEF1 DDX5 RPS6KC1 MYO15B STIP1 CHD6 MMP2 OR7A10 DYNC1H1 MYOM3 MUC19 ST3GAL4 HUWE1 OMG PDE12 ASNS PLXNA4 FBXO43 ATM EPB41L2 | 9.17e-07 | 736 | 285 | 21 | 29676528 |
| Pubmed | ABCC4 POP4 SPCS2 NCF2 ITGA2 NEB ERBIN DDX5 CSDE1 FAT1 NF1 SV2A SCN2A GNPDA2 FEN1 MMP2 MBD4 SEC23B RAB17 RHBDF2 GNPTAB PHTF2 ST3GAL4 AIFM2 NOP58 ANKEF1 IRAK3 DCAF11 FCMR | 1.10e-06 | 1293 | 285 | 29 | 15342556 | |
| Pubmed | ABL2 RPN1 ERBIN DDX5 CSDE1 PSMD6 OSBPL8 PDZD8 STIP1 AP3D1 DYNC1H1 VDAC1 APMAP PSD3 NUP214 BCAP31 CCDC88A IGF2R PATJ EPB41L2 | 1.95e-06 | 708 | 285 | 20 | 39231216 | |
| Pubmed | SPCS2 PLXND1 ZZEF1 ANKRD27 ZC3H4 ARAP1 SDK2 E2F3 CHD8 NCAPH TUBGCP6 CCDC88A HS2ST1 SENP6 PCNX1 AKAP11 NBR1 | 2.14e-06 | 529 | 285 | 17 | 14621295 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TPP2 ACADVL RPN1 PSMA3 XAB2 DDX5 CSDE1 ZC3H4 FEN1 OSBPL8 STIP1 AP3D1 CNN2 DYNC1H1 SEC23B SEC23A KIF11 VDAC1 H1-10 SRSF5 SCAF8 HUWE1 NCAPH NIFK NOP58 SMARCA4 SMARCC1 EIF3H NBR1 EPB41L2 | 2.22e-06 | 1415 | 285 | 30 | 28515276 |
| Pubmed | 2.33e-06 | 47 | 285 | 6 | 8812413 | ||
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | ACADVL RPN1 SPCS2 NDUFS1 PSMD6 STIP1 DYNC1H1 SEC23A KIF11 VDAC1 FKBP10 TMEM43 HUWE1 NOP58 BCAP31 | 2.54e-06 | 422 | 285 | 15 | 27342126 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TPP2 PSMA3 ZZEF1 DDX5 CSDE1 PSMD6 PARP6 GNPDA2 FEN1 UGP2 STIP1 AP3D1 CNN2 DYNC1H1 SEC23B SEC23A USP47 FKBP10 H1-10 SRSF5 UBA2 HUWE1 NCAPH PDE12 ASNS PES1 CNDP2 DCAF11 EIF3H EPB41L2 | 3.86e-06 | 1455 | 285 | 30 | 22863883 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DAB2IP ABL2 TRIO NF1 GNA11 STIP1 GNAQ DYNC1H1 AGAP2 BEGAIN AKAP11 EPB41L2 | 4.12e-06 | 281 | 285 | 12 | 28706196 |
| Pubmed | 4.14e-06 | 14 | 285 | 4 | 1648219 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 4.14e-06 | 14 | 285 | 4 | 26196244 | |
| Pubmed | 4.26e-06 | 52 | 285 | 6 | 26633812 | ||
| Pubmed | LRRK2 SQOR PTPRD ZC3H4 CNTN5 SDK1 SLC25A48 PMS1 RAB17 SLC36A4 PSD3 PHTF2 E2F3 TUBGCP6 ZBTB46 KCNIP4 RASEF GREB1 HAS2 PATJ PDZD2 | 4.42e-06 | 814 | 285 | 21 | 23251661 | |
| Pubmed | ABCC4 ANKRD27 RPS6KC1 SV2A OSBPL8 STARD3 PDZD8 SEC23A TMEM43 BCAP31 IGF2R LRIG1 NETO2 SAR1B AKAP11 ATP4A | 4.98e-06 | 504 | 285 | 16 | 34432599 | |
| Pubmed | Assembly of high order G alpha q-effector complexes with RGS proteins. | 5.38e-06 | 5 | 285 | 3 | 18936096 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TANC2 DDX5 MYO15B NF1 FEN1 DYNC1H1 SEC23B SEC23A ARAP1 KIF11 SRSF5 SCAF8 CHD8 HUWE1 NCAPH SMARCA4 ATM | 7.53e-06 | 582 | 285 | 17 | 20467437 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH2 MYH6 ACADVL RPN1 PSMA3 ITGA2 DNAJB14 NDUFS1 CNN2 DYNC1H1 SEC23B SEC23A H1-10 APMAP HUWE1 NCAPH SAR1A RASEF | 7.88e-06 | 647 | 285 | 18 | 26618866 |
| Pubmed | 8.32e-06 | 162 | 285 | 9 | 25826454 | ||
| Pubmed | LARP6 TRIO PSMA3 GNPTG LRP1B XAB2 CSDE1 PTPRD DENND6B OSBPL8 PDZD8 DCLK2 CHD6 TAF6 MBD4 DYNC1H1 USP47 AGAP2 ZNF793 GNPTAB E2F3 HUWE1 CPNE5 PPT1 SMARCA4 SENP6 ATM | 8.63e-06 | 1285 | 285 | 27 | 35914814 | |
| Pubmed | Regulation of error-prone translesion synthesis by Spartan/C1orf124. | 8.99e-06 | 59 | 285 | 6 | 23254330 | |
| Pubmed | RPN1 PSMA3 SPCS2 ZZEF1 NDUFS1 DDX5 NF1 OSBPL8 VDAC1 TMEM43 HUWE1 SAR1A IGF2R PPT1 HS2ST1 SMARCA4 PCNX1 EIF3H | 9.69e-06 | 657 | 285 | 18 | 36180527 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | CDCA2 CSDE1 AP3D1 CNN2 DYNC1H1 KIF11 NUP214 NCAPH CCDC88A NBR1 EPB41L2 | 9.79e-06 | 256 | 285 | 11 | 33397691 |
| Pubmed | TPP2 TRIO RPN1 SPCS2 TRMT11 NDUFS1 XAB2 DDX5 CSDE1 PSMD6 FAT1 OSBPL8 STIP1 AP3D1 CNN2 DYNC1H1 SEC23B KIF11 FKBP10 NUP214 TMEM43 IGF2R PPT1 SAR1B PES1 NBR1 EPB41L2 | 1.02e-05 | 1297 | 285 | 27 | 33545068 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | PSMA3 DDX5 PSMD6 PHKA1 ZC3H4 FEN1 UGP2 STIP1 AP3D1 DYNC1H1 SEC23A KIF11 VDAC1 FKBP10 H1-10 SRSF5 UBA2 HUWE1 NCAPH NOP58 PPT1 ASNS EIF3H PATJ EPB41L2 | 1.05e-05 | 1149 | 285 | 25 | 35446349 |
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 1.11e-05 | 92 | 285 | 7 | 15840729 | |
| Pubmed | TRIO TMEM94 MECOM ERBIN NDUFS1 YTHDF1 OSBPL8 PDZD8 CHD6 SCAF8 NUP214 HUWE1 SAR1A CCDC88A IGF2R PES1 SMARCA4 PATJ NBR1 | 1.19e-05 | 733 | 285 | 19 | 34672954 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | RPN1 PSMA3 SPCS2 DNAJB14 CSDE1 FEN1 OSBPL8 DYNC1H1 SEC23A KIF11 VDAC1 FKBP10 NUP214 HUWE1 BCAP31 PDE12 IGF2R LRIG1 HS2ST1 ASNS PES1 NBR1 | 1.24e-05 | 942 | 285 | 22 | 31073040 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RPN1 XAB2 DDX5 YTHDF1 CDCA2 SAFB ZC3H4 FEN1 TAF6 MBD4 PHIP VDAC1 PMS1 H1-10 CHD8 NUP214 KIF20B NIFK NOP58 SMARCA4 SENP6 SMARCC1 | 1.51e-05 | 954 | 285 | 22 | 36373674 |
| Pubmed | ACADVL RPN1 ERBIN DNAJB14 NDUFS1 OSBPL8 PDZD8 STIP1 AP3D1 PMS1 FKBP10 H1-10 PSD3 TUBGCP6 NIFK AIFM2 NOP58 BCAP31 CCDC88A PDE12 IGF2R ASNS PES1 CNDP2 AKAP11 ATM NBR1 EPB41L2 MAST3 | 1.60e-05 | 1487 | 285 | 29 | 33957083 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP TANC2 TRIO TMEM94 TRMT11 PLXND1 SLC35E2B ZZEF1 FAT1 PDZD8 CACNA1H FEM1A AP3D1 DYNC1H1 ARAP1 RHBDF2 DOCK9 MYOM3 CHD8 NUP214 HUWE1 GTF2IRD1 IGF2R PCNX1 | 1.63e-05 | 1105 | 285 | 24 | 35748872 |
| Pubmed | TPP2 DDX5 CSDE1 PSMD6 STIP1 CNN2 SEC23B SEC23A KIF11 NUP214 KIF20B PDE12 SMARCA4 SMARCC1 EIF3H | 1.66e-05 | 494 | 285 | 15 | 26831064 | |
| Pubmed | 1.75e-05 | 136 | 285 | 8 | 22304920 | ||
| Pubmed | 1.86e-05 | 7 | 285 | 3 | 17452640 | ||
| Pubmed | 1.86e-05 | 7 | 285 | 3 | 16059920 | ||
| Pubmed | 1.86e-05 | 7 | 285 | 3 | 30323305 | ||
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | TPP2 ACADVL ITGA2 SQOR NDUFS1 STIP1 FKBP10 PREX2 NOP58 CCDC88A | 1.93e-05 | 226 | 285 | 10 | 37839992 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | XAB2 DDX5 SAFB STIP1 DYNC1H1 KIF11 UBA2 CHD8 NUP214 HUWE1 ASNS SMARCA4 | 2.19e-05 | 332 | 285 | 12 | 32786267 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | TPP2 DDX5 FEN1 DNAH8 AP3D1 DYNC1H1 SEC23B KIF11 UBA2 HUWE1 NCAPH NOP58 PDE12 ASNS PES1 SMARCA4 SMARCC1 EPB41L2 | 2.42e-05 | 704 | 285 | 18 | 29955894 |
| Pubmed | A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export. | RPN1 SPCS2 DNAJB14 STARD3 DYNC1H1 SEC23A VDAC1 APMAP TMEM43 HUWE1 CPNE5 IGF2R SMARCA4 | 2.46e-05 | 392 | 285 | 13 | 33144569 |
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 2.50e-05 | 186 | 285 | 9 | 33637726 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | PSMA3 ERBIN DNAJB14 XAB2 DDX5 CSDE1 PSMD6 SAFB FEN1 UGP2 GNA11 STIP1 CNN2 SEC23A KIF11 FKBP10 APMAP NUP214 HUWE1 NCAPH NOP58 BCAP31 PDE12 IGF2R IGHG2 ASNS SMARCC1 | 2.56e-05 | 1367 | 285 | 27 | 32687490 |
| Pubmed | PSG1 SAFB GNA11 GRIN3B OR7A17 OR7A10 AP3D1 CD22 SMARCA4 ATP4A MAST3 | 2.56e-05 | 284 | 285 | 11 | 15057824 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPP2 RPN1 PSMA3 DDX5 YTHDF1 CSDE1 PSMD6 FEN1 AP3D1 DYNC1H1 VDAC1 UBA2 NCAPH SAR1A BCAP31 SAR1B SMARCA4 SMARCC1 EIF3H EPB41L2 | 2.66e-05 | 847 | 285 | 20 | 35235311 |
| Pubmed | POP4 PSMA3 CSDE1 PSMD6 STIP1 DYNC1H1 USP47 HUWE1 NCAPH CCDC88A SMARCA4 SMARCC1 EPB41L2 | 2.95e-05 | 399 | 285 | 13 | 37536630 | |
| Pubmed | 2.96e-05 | 8 | 285 | 3 | 9307024 | ||
| Pubmed | ZZEF1 ANKRD27 XAB2 CSDE1 ZC3H4 STARD3 AP3D1 SEC23B PMS1 EEFSEC SCAF8 CHD8 AIFM2 CCDC88A OSBPL3 SMARCC1 PATJ | 3.08e-05 | 650 | 285 | 17 | 38777146 | |
| Pubmed | 3.08e-05 | 191 | 285 | 9 | 31177093 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | TANC2 ABCC4 ABL2 TMEM94 NDUFS1 SNX13 CSDE1 STARD3 GNA11 KIF11 RPF1 TMEM43 SAR1A CCDC88A IGF2R TENM3 OSBPL3 NBR1 | 3.19e-05 | 719 | 285 | 18 | 35337019 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RPN1 NDUFS1 XAB2 DDX5 SAFB ZC3H4 FEN1 CHD6 AP3D1 DYNC1H1 SEC23B VDAC1 SRSF5 RNPC3 APMAP TMEM43 GTF2IRD1 NIFK NOP58 PES1 SMARCA4 SMARCC1 ATM | 3.43e-05 | 1082 | 285 | 23 | 38697112 |
| Pubmed | 3.71e-05 | 46 | 285 | 5 | 21102462 | ||
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | RPN1 SPCS2 ITGA2 ODR4 OSBPL8 PDZD8 SEC23B FKBP10 TMEM43 SAR1A BCAP31 IGF2R OSBPL3 SAR1B | 3.73e-05 | 468 | 285 | 14 | 31056421 |
| Pubmed | ZC3H4 CHD6 PHIP CHD8 NUP214 HUWE1 NCAPH METTL6 NIFK NOP58 PES1 SMARCA4 SMARCC1 EIF3H | 3.81e-05 | 469 | 285 | 14 | 27634302 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | PSMA3 LRRK2 NEB DDX5 FAT1 SPON2 UGP2 GCA GNA11 GNAQ DYNC1H1 VDAC1 COL6A1 REXO5 RAB17 HUWE1 CPNE5 IGF2R CNDP2 ABCB11 EIF3H PATJ | 3.88e-05 | 1016 | 285 | 22 | 19056867 |
| Pubmed | 3.88e-05 | 76 | 285 | 6 | 27542412 | ||
| Pubmed | ACADVL RPN1 SQOR NDUFS1 DDX5 NF1 SCN2A FEN1 UGP2 STIP1 DYNC1H1 VDAC1 H1-10 SRSF5 ZNF397 NOP58 PES1 CNDP2 SMARCA4 | 4.12e-05 | 803 | 285 | 19 | 36517590 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ACADVL XAB2 DDX5 PSMD6 SAFB NF1 ZC3H4 STIP1 PHIP DYNC1H1 SEC23A H1-10 APMAP NUP214 HUWE1 SAR1A NIFK NOP58 IGF2R PES1 SMARCA4 EPB41L2 | 4.36e-05 | 1024 | 285 | 22 | 24711643 |
| Pubmed | TPP2 ABCC4 RPN1 PSMA3 NDUFS1 FEN1 DYNC1H1 SEC23A USP47 SRSF5 UBA2 HUWE1 SAR1A IGF2R IGHG2 ASNS PES1 CNDP2 EIF3H EPB41L2 | 4.39e-05 | 878 | 285 | 20 | 37223481 | |
| Pubmed | 4.41e-05 | 9 | 285 | 3 | 10829070 | ||
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | TPP2 RPN1 PSMA3 NDUFS1 DDX5 PSMD6 OSBPL8 GNA11 VDAC1 H1-10 NIFK NOP58 IGHG2 PES1 CD58 EPB41L2 | 4.53e-05 | 604 | 285 | 16 | 37616343 |
| Pubmed | POP4 RPN1 DDX5 ODR4 DYNC1H1 RPF1 H1-10 NIFK NOP58 CCDC88A PPT1 IGHG2 PES1 SMARCA4 | 5.23e-05 | 483 | 285 | 14 | 36912080 | |
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 5.60e-05 | 118 | 285 | 7 | 27377895 | |
| Pubmed | 6.26e-05 | 10 | 285 | 3 | 12533510 | ||
| Pubmed | 6.68e-05 | 27 | 285 | 4 | 19026994 | ||
| Pubmed | The Role of Mutation Rates of GNAQ or GNA11 in Cases of Uveal Melanoma in Japan. | 6.69e-05 | 2 | 285 | 2 | 28248732 | |
| Pubmed | Comparative pathology of murine mucolipidosis types II and IIIC. | 6.69e-05 | 2 | 285 | 2 | 19261645 | |
| Pubmed | Molecular genetic testing of uveal melanoma from routinely processed and stained cytology specimens. | 6.69e-05 | 2 | 285 | 2 | 21945171 | |
| Pubmed | Cloning and functional characterization of mammalian homologues of the COPII component Sec23. | 6.69e-05 | 2 | 285 | 2 | 8898360 | |
| Pubmed | 6.69e-05 | 2 | 285 | 2 | 34341521 | ||
| Pubmed | Functional overlap between the mammalian Sar1a and Sar1b paralogs in vivo. | 6.69e-05 | 2 | 285 | 2 | 38687799 | |
| Pubmed | 6.69e-05 | 2 | 285 | 2 | 30150416 | ||
| Pubmed | 6.69e-05 | 2 | 285 | 2 | 9607776 | ||
| Pubmed | Silencing of mammalian Sar1 isoforms reveals COPII-independent protein sorting and transport. | 6.69e-05 | 2 | 285 | 2 | 23433038 | |
| Pubmed | 6.69e-05 | 2 | 285 | 2 | 26628681 | ||
| Pubmed | High Expression of CD58 and ALDH1A3 Predicts a Poor Prognosis in Basal-like Breast Cancer. | 6.69e-05 | 2 | 285 | 2 | 36288878 | |
| Pubmed | 6.69e-05 | 2 | 285 | 2 | 17552882 | ||
| Pubmed | Modulation of membrane rigidity by the human vesicle trafficking proteins Sar1A and Sar1B. | 6.69e-05 | 2 | 285 | 2 | 22974979 | |
| Pubmed | 6.69e-05 | 2 | 285 | 2 | 19659762 | ||
| Pubmed | Frequent and Yet Unreported GNAQ and GNA11 Mutations are Found in Uveal Melanomas. | 6.69e-05 | 2 | 285 | 2 | 29209985 | |
| Pubmed | 6.69e-05 | 2 | 285 | 2 | 28474257 | ||
| Pubmed | 6.69e-05 | 2 | 285 | 2 | 28789966 | ||
| GeneFamily | Cadherin related | 3.21e-05 | 17 | 202 | 4 | 24 | |
| GeneFamily | PDZ domain containing | 5.37e-05 | 152 | 202 | 9 | 1220 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.39e-05 | 161 | 202 | 9 | 593 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 2.12e-04 | 11 | 202 | 3 | 1315 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 3.76e-04 | 31 | 202 | 4 | 357 | |
| GeneFamily | Dyneins, axonemal | 8.32e-04 | 17 | 202 | 3 | 536 | |
| GeneFamily | CD molecules|MRH domain containing | 1.81e-03 | 6 | 202 | 2 | 1233 | |
| GeneFamily | Netrins | 1.81e-03 | 6 | 202 | 2 | 661 | |
| GeneFamily | Fibronectin type III domain containing | 2.17e-03 | 160 | 202 | 7 | 555 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.25e-03 | 206 | 202 | 8 | 682 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 2.51e-03 | 7 | 202 | 2 | 1201 | |
| GeneFamily | Acyl-CoA synthetase family | 2.96e-03 | 26 | 202 | 3 | 40 | |
| GeneFamily | EF-hand domain containing | 3.28e-03 | 219 | 202 | 8 | 863 | |
| GeneFamily | Plexins | 4.25e-03 | 9 | 202 | 2 | 683 | |
| Coexpression | GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_DN | RPN1 CDK19 PMS1 APMAP CCDC88A STS CD22 RNASET2 SMARCC1 ATM EPB41L2 | 1.21e-05 | 199 | 284 | 11 | M7129 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | TPP2 TRIO ZZEF1 NDUFS1 RPS6KC1 CDCA2 PSMD6 FAT1 PTPRD CHD6 ALDH1A3 NOS1 SDK1 VDAC1 TPST1 SDK2 SRSF5 APMAP PSD3 ST3GAL4 SKP2 ARL4C TENM3 LRIG1 AP5M1 SMARCA4 MAPK8 | 1.62e-05 | 1009 | 284 | 27 | M157 |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | TANC2 TRIO ACADVL MECOM ITGA2 ERBIN DDX5 TPST1 OSBPL3 KCNIP4 | 1.67e-05 | 169 | 284 | 10 | M39230 |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | TANC2 MECOM ITGA2 LRP1B SCN2A GNAQ RNPC3 OSBPL3 KCNIP4 MAPK8 | 1.85e-05 | 171 | 284 | 10 | M39234 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | BOC LRRK2 RFTN2 LRP1B FAT1 FAT2 GCA NTN1 VCAM1 COL6A1 FAT3 RALGPS2 MUC19 HEATR5A NRBP2 BCO2 PPT1 LRIG1 HAS2 | 1.86e-05 | 574 | 284 | 19 | M39056 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TANC2 FRMPD4 LRRK2 NEB LRP1B TENM2 DNAJB14 TBC1D32 FAT2 SV2A BLID CNTN5 SCN2A DCLK2 GNAQ ZNF793 GNPTAB MUC19 NTNG1 CPNE5 LGR5 ARL4C CCDC88A ASNS PLXNA4 CNTNAP4 KCNIP4 IRX2 | 3.03e-05 | 1106 | 284 | 28 | M39071 |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 3.17e-05 | 182 | 284 | 10 | MM993 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | BOC LRRK2 MECOM DNAJB14 GAB2 CDCA2 PHEX FAP PTPRD ODR4 SCN2A GCA NTN1 GNAQ VCAM1 PHTF2 NTNG1 HUWE1 SKP2 KIF20B ZBTB46 PDE12 LRIG1 NETO2 CNTNAP4 IRAK3 HAS2 | 9.06e-06 | 819 | 275 | 27 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | TMEM67 ABCC4 OR2W1 MECOM CDCA2 HOXB8 SCN2A FEN1 MMP2 NOS1 KIF11 RPF1 H1-10 SDK2 FAT3 E2F3 NCAPH KIF20B TENM3 NETO2 RAB3IP RASEF GREB1 HAS2 PDZD2 | 1.60e-05 | 749 | 275 | 25 | gudmap_kidney_P3_CapMes_Crym_1000 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRMPD4 ABCA12 NEB LRP1B TRDN FAT1 PTPRD SCN2A PTPRQ DNAH9 SDK1 ATP13A4 FAT3 DNAH1 XIRP2 CNTNAP4 | 7.17e-14 | 184 | 285 | 16 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRMPD4 ABCA12 NEB LRP1B TRDN FAT1 PTPRD SCN2A PTPRQ DNAH9 SDK1 ATP13A4 FAT3 DNAH1 XIRP2 CNTNAP4 | 7.17e-14 | 184 | 285 | 16 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRMPD4 ABCA12 NEB LRP1B TRDN FAT1 PTPRD SCN2A PTPRQ DNAH9 SDK1 ATP13A4 FAT3 DNAH1 XIRP2 CNTNAP4 | 7.17e-14 | 184 | 285 | 16 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | FRMPD4 SVEP1 PHEX PTPRD MMP2 SDK1 VCAM1 ACSS3 COL6A1 SDK2 FAT3 RALGPS2 NTNG1 TENM3 PLXNA4 HAS2 | 1.28e-13 | 191 | 285 | 16 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | FRMPD4 SVEP1 PHEX PTPRD MMP2 SDK1 VCAM1 ACSS3 COL6A1 FAT3 RALGPS2 NTNG1 TENM3 PLXNA4 HAS2 | 1.66e-12 | 189 | 285 | 15 | a153b83314cf52808f685296cff8c95af3f4983d |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | FRMPD4 SVEP1 PHEX PTPRD MMP2 SDK1 VCAM1 ACSS3 COL6A1 FAT3 RALGPS2 NTNG1 TENM3 PLXNA4 HAS2 | 2.09e-12 | 192 | 285 | 15 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | FRMPD4 SVEP1 PHEX PTPRD MMP2 SDK1 VCAM1 ACSS3 COL6A1 FAT3 RALGPS2 NTNG1 TENM3 PLXNA4 | 2.91e-11 | 192 | 285 | 14 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | FRMPD4 SVEP1 PHEX PTPRD MMP2 SDK1 ACSS3 COL6A1 FAT3 RALGPS2 PSD3 NTNG1 TENM3 PLXNA4 | 3.12e-11 | 193 | 285 | 14 | fb28717fadd06c3840636d25409ce80c9254bd34 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | TANC2 TRIO PSG4 MECOM ITGA2 LRP1B FAT1 SCN2A GTF2IRD1 ARL4C OSBPL3 SLCO2A1 KCNIP4 MAPK8 | 3.34e-11 | 194 | 285 | 14 | 46070fbb0ee0eb9e1801c43b73a15707471056dc |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | TANC2 TRIO PSG4 MECOM ITGA2 LRP1B FAT1 SCN2A GTF2IRD1 ARL4C OSBPL3 SLCO2A1 KCNIP4 MAPK8 | 3.34e-11 | 194 | 285 | 14 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | FRMPD4 SVEP1 PHEX PTPRD MMP2 SDK1 ACSS3 COL6A1 SDK2 FAT3 RALGPS2 NTNG1 TENM3 PLXNA4 | 3.34e-11 | 194 | 285 | 14 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | SVEP1 PHEX PTPRD MMP2 SDK1 VCAM1 COL6A1 RALGPS2 PSD3 NTNG1 PREX2 PLXNA4 HAS2 EPB41L2 | 5.02e-11 | 200 | 285 | 14 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SVEP1 PHEX MMP2 ALDH1A3 SDK1 VCAM1 ACSS3 COL6A1 SDK2 RALGPS2 TENM3 PLXNA4 HAS2 | 3.08e-10 | 189 | 285 | 13 | e9d5e858e320c6e9913c1ea6a54967d21eda605f |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | FRMPD4 SVEP1 PHEX PTPRD MMP2 SDK1 VCAM1 ACSS3 COL6A1 FAT3 RALGPS2 NTNG1 PLXNA4 | 3.29e-10 | 190 | 285 | 13 | 841cd55861b43578d704418b9bc0af2e8b88323a |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SVEP1 PHEX PTPRD MMP2 SDK1 VCAM1 ACSS3 COL6A1 FAT3 RALGPS2 NTNG1 TENM3 PLXNA4 | 3.74e-10 | 192 | 285 | 13 | 3d0cb19f037f604253d7d728689aeaa94251e92b |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SVEP1 PHEX MMP2 ALDH1A3 SDK1 VCAM1 ACSS3 COL6A1 SDK2 RALGPS2 TENM3 PLXNA4 HAS2 | 3.74e-10 | 192 | 285 | 13 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SVEP1 PHEX MMP2 ALDH1A3 SDK1 VCAM1 COL6A1 SDK2 FAT3 RALGPS2 TENM3 PLXNA4 HAS2 | 3.74e-10 | 192 | 285 | 13 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | FRMPD4 SVEP1 PHEX PTPRD SDK1 VCAM1 SDK2 FAT3 RALGPS2 NTNG1 TENM3 PLXNA4 HAS2 | 4.25e-10 | 194 | 285 | 13 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | SVEP1 PHEX UGP2 MMP2 ALDH1A3 SDK1 VCAM1 FKBP10 COL6A1 SDK2 RALGPS2 TENM3 HAS2 | 5.82e-10 | 199 | 285 | 13 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | PTH1R SVEP1 PHEX PTPRD MMP2 ALDH1A3 SDK1 VCAM1 COL6A1 SDK2 TENM3 PLXNA4 HAS2 | 5.82e-10 | 199 | 285 | 13 | 8b86c69aaf60feff53aa782559cfece7342a23de |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | SVEP1 PHEX UGP2 MMP2 ALDH1A3 SDK1 VCAM1 FKBP10 COL6A1 SDK2 RALGPS2 TENM3 HAS2 | 5.82e-10 | 199 | 285 | 13 | ba586690f88fd051f449753bfe7603a2cb431782 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | SVEP1 PHEX UGP2 MMP2 ALDH1A3 SDK1 VCAM1 FKBP10 COL6A1 SDK2 RALGPS2 TENM3 HAS2 | 5.82e-10 | 199 | 285 | 13 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | SVEP1 PHEX PTPRD MMP2 VCAM1 FKBP10 COL6A1 SDK2 RALGPS2 PSD3 NTNG1 PREX2 HAS2 | 6.19e-10 | 200 | 285 | 13 | 44a68bacdb3d5bf563bd35952176995850933a81 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | SVEP1 PHEX PTPRD MMP2 VCAM1 FKBP10 COL6A1 SDK2 RALGPS2 PSD3 NTNG1 PREX2 HAS2 | 6.19e-10 | 200 | 285 | 13 | dc61016c61729f69649cfb21f6264e685ce83dea |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | LRRK2 LRP1B CNTN5 SCN2A DNAH8 TET3 H1-10 MUC19 RFX6 CCDC88A CNTNAP4 IRAK3 | 3.10e-09 | 186 | 285 | 12 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SVEP1 PHEX PTPRD ALDH1A3 SDK1 VCAM1 SDK2 RALGPS2 PSD3 TENM3 PLXNA4 HAS2 | 3.95e-09 | 190 | 285 | 12 | 45df8fee00f8949937863159d7aa042e72748d9b |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SVEP1 PHEX PTPRD MMP2 SDK1 VCAM1 COL6A1 TPST1 SDK2 TENM3 PLXNA4 HAS2 | 4.44e-09 | 192 | 285 | 12 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SVEP1 PHEX PTPRD MMP2 SDK1 VCAM1 COL6A1 TPST1 SDK2 TENM3 PLXNA4 HAS2 | 4.44e-09 | 192 | 285 | 12 | df1545670370fb1010c567cd059c2783eab315f7 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SVEP1 PHEX PTPRD SDK1 ACSS3 COL6A1 SDK2 FAT3 RALGPS2 NTNG1 TENM3 PLXNA4 | 4.44e-09 | 192 | 285 | 12 | deeecd26972241846b4cb998edf0c7a87ff0c4df |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | ITGA2 TENM2 PTH1R SVEP1 PHEX FAP SDK1 FKBP10 COL6A1 FAT3 NTNG1 TENM3 | 4.71e-09 | 193 | 285 | 12 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SVEP1 PHEX PTPRD MMP2 SDK1 ACSS3 COL6A1 FAT3 RALGPS2 TENM3 PLXNA4 HAS2 | 4.99e-09 | 194 | 285 | 12 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | TANC2 LRRK2 MECOM ITGA2 LRP1B CACNA1H NOS1 TPST1 GTF2IRD1 OSBPL3 KCNIP4 IRX2 | 5.60e-09 | 196 | 285 | 12 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | SVEP1 PHEX PTPRD MMP2 ALDH1A3 VCAM1 COL6A1 SDK2 NTNG1 TENM3 HAS2 EPB41L2 | 5.93e-09 | 197 | 285 | 12 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | SVEP1 PHEX PTPRD MMP2 VCAM1 FKBP10 COL6A1 SDK2 NTNG1 TENM3 PLXNA4 HAS2 | 6.65e-09 | 199 | 285 | 12 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | SVEP1 PHEX PTPRD MMP2 VCAM1 FKBP10 COL6A1 SDK2 RALGPS2 PSD3 NTNG1 HAS2 | 7.03e-09 | 200 | 285 | 12 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | SVEP1 PHEX PTPRD MMP2 VCAM1 FKBP10 COL6A1 SDK2 RALGPS2 PSD3 NTNG1 HAS2 | 7.03e-09 | 200 | 285 | 12 | 50ca6550998e461ef26dd670351060bd940765a8 |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | ITGA2 SVEP1 PHEX FAP PTPRD MMP2 FKBP10 COL6A1 FAT3 NTNG1 ARL4D HAS2 | 7.03e-09 | 200 | 285 | 12 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | SVEP1 PHEX PTPRD MMP2 VCAM1 FKBP10 COL6A1 SDK2 PSD3 NTNG1 ST3GAL4 HAS2 | 7.03e-09 | 200 | 285 | 12 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | TANC2 BOC ABCC4 LRRK2 ITGA2 PLA1A ATP13A4 MBIP RASEF PATJ IRX2 | 3.89e-08 | 188 | 285 | 11 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | PSG4 MECOM ITGA2 LRP1B SCN2A NTN1 RNPC3 GTF2IRD1 OSBPL3 KCNIP4 PATJ | 4.11e-08 | 189 | 285 | 11 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | TANC2 IL18 MECOM ITGA2 SCN2A NTN1 RALGPS2 PSD3 GTF2IRD1 OSBPL3 KCNIP4 | 4.83e-08 | 192 | 285 | 11 | f7e7491426bbd6ed29a465b58bf67acb93dbb90a |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SVEP1 PHEX PTPRD MMP2 SDK1 COL6A1 SDK2 FAT3 TENM3 PLXNA4 HAS2 | 4.83e-08 | 192 | 285 | 11 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | CDH23 TENM2 PTH1R SVEP1 PHEX SDK1 COL6A1 SDK2 FAT3 NTNG1 PREX2 | 5.09e-08 | 193 | 285 | 11 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | TENM2 PTH1R SVEP1 PHEX FAP PTPRD SDK1 COL6A1 SDK2 FAT3 NTNG1 | 5.09e-08 | 193 | 285 | 11 | acad568621ed677031797b8c2e34dafea798d681 |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | PTH1R SVEP1 PHEX FAP PTPRD MMP2 FKBP10 COL6A1 FAT3 NTNG1 HAS2 | 5.37e-08 | 194 | 285 | 11 | 8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | DAB2IP BOC PTH1R PHEX MMP2 FKBP10 SDK2 FAT3 ARL4D TENM3 PDZD2 | 5.37e-08 | 194 | 285 | 11 | 292ce9021678534c9eedb367b9772a9d976208a8 |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | CDCA2 FAP KIF11 FKBP10 COL6A1 REXO5 NCAPH KIF20B TENM3 FBXO43 HAS2 | 5.96e-08 | 196 | 285 | 11 | 2ce8a787f2731faa913d20342d73041d59468f27 |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | BOC LARP6 LRP1B SVEP1 PTPRD PLA2G2A MMP2 ALDH1A3 FKBP10 COL6A1 PLXNA4 | 6.28e-08 | 197 | 285 | 11 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | BOC LARP6 LRP1B SVEP1 PTPRD PLA2G2A MMP2 ALDH1A3 FKBP10 COL6A1 PLXNA4 | 6.28e-08 | 197 | 285 | 11 | 17344464fdcc5ba0c03959696b97c195f11e644c |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | BOC LARP6 LRP1B SVEP1 PTPRD PLA2G2A MMP2 ALDH1A3 FKBP10 COL6A1 PLXNA4 | 6.28e-08 | 197 | 285 | 11 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | TANC2 CDH23 ITGA2 FAP PTPRD OSBPL8 MMP2 SDK2 PSD3 ST3GAL4 TENM3 | 6.28e-08 | 197 | 285 | 11 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | CDH23 ITGA2 SVEP1 FAP MMP2 SDK1 FKBP10 COL6A1 FAT3 NTNG1 TENM3 | 6.61e-08 | 198 | 285 | 11 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | TANC2 ABCC4 IRX5 LRRK2 ITGA2 FAT1 PLA1A ATP13A4 MBIP PATJ ACSL5 | 6.61e-08 | 198 | 285 | 11 | 285f729140b1df029c24f6ca1d2438470ac51794 |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | LARP6 PTH1R FAP FAT1 PTPRD MMP2 FKBP10 COL6A1 TPST1 FAT3 HAS2 | 6.61e-08 | 198 | 285 | 11 | 9d61483b0decac2fe90045b3474843360b2c49b3 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | LARP6 PTH1R SVEP1 FAT1 PTPRD MMP2 FKBP10 COL6A1 TPST1 FAT3 HAS2 | 6.61e-08 | 198 | 285 | 11 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Mesothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | BOC KCTD4 SVEP1 PTPRQ PLA2G2A ALDH1A3 VCAM1 FKBP10 COL6A1 NTNG1 TENM3 | 6.96e-08 | 199 | 285 | 11 | ca970114b5aef4518ce580897a62ac88688b2671 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | SVEP1 PHEX PTPRD MMP2 VCAM1 COL6A1 SDK2 PSD3 NTNG1 PREX2 EPB41L2 | 6.96e-08 | 199 | 285 | 11 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | SVEP1 PHEX PTPRD MMP2 VCAM1 COL6A1 SDK2 RALGPS2 NTNG1 TENM3 HAS2 | 6.96e-08 | 199 | 285 | 11 | e1849505b92820a219c5a2c35492bdd55579fb48 |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | BOC PTH1R SVEP1 MMP2 SDK1 FKBP10 COL6A1 FAT3 NTNG1 TENM3 EPB41L2 | 6.96e-08 | 199 | 285 | 11 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.85e-08 | 162 | 285 | 10 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Int-URO-Lymphocyte-B-B_intermediate|Int-URO / Disease, Lineage and Cell Type | 1.38e-07 | 168 | 285 | 10 | 5b3fb1fc8fea810c6d4e6feb42c24fb57e8066de | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.73e-07 | 172 | 285 | 10 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | BOC ABCC4 RFTN2 SLC27A1 CACNA1H SDK1 FKBP10 COL6A1 ZBTB46 TTLL6 | 2.25e-07 | 177 | 285 | 10 | ac90e4ce5be304a5a7473736397327010f2d1999 |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | BOC NEB SVEP1 PLA2G2A NTN1 MMP2 ALDH1A3 SLC25A48 COL6A1 GREB1 | 2.37e-07 | 178 | 285 | 10 | a493a277d175e5e153410a745b26ebe2e0839ea0 |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|356C / Donor, Lineage, Cell class and subclass (all cells) | BOC NEB SVEP1 PLA2G2A NTN1 MMP2 ALDH1A3 SLC25A48 COL6A1 GREB1 | 2.37e-07 | 178 | 285 | 10 | 371218babddfd3d8a7bb82a46ce65327ee3fcf12 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | ABCC4 OR2G6 LRRK2 FAT1 ANKRD34B PTPRD VCAM1 MYOM3 SLC28A1 GREB1 | 2.50e-07 | 179 | 285 | 10 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.63e-07 | 180 | 285 | 10 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.77e-07 | 181 | 285 | 10 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-07 | 140 | 285 | 9 | e16e31d6310347f1fe72051dd0d7650d090e6d3c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 3.39e-07 | 185 | 285 | 10 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 3.39e-07 | 185 | 285 | 10 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | TANC2 ABCC4 LRRK2 MECOM ITGA2 PTPRD AP3D1 ZC3H12A DOCK9 PATJ | 3.56e-07 | 186 | 285 | 10 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.74e-07 | 187 | 285 | 10 | f1d0fc625e0e7881b3f290742fd7148d995eb71e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.74e-07 | 187 | 285 | 10 | 02e7246ef5ad41773d14426254e139b156d45c1d | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|kidney / Disease (COVID-19 only), tissue and cell type | 3.74e-07 | 187 | 285 | 10 | 2ce8038d9d1302e850c1bb536e755598f77ba4b9 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.74e-07 | 187 | 285 | 10 | 08c73d125e0638c9e9878165bba2442c266c8a48 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | TANC2 MECOM ITGA2 LRP1B SCN2A NOS1 GTF2IRD1 OSBPL3 KCNIP4 PATJ | 3.74e-07 | 187 | 285 | 10 | 77886f99c229610abd28c4c370d2c7d1536c9782 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | PSG4 MECOM ITGA2 LRP1B SCN2A NTN1 GTF2IRD1 OSBPL3 KCNIP4 PATJ | 3.74e-07 | 187 | 285 | 10 | f124d2c699b717b7c02a1a70493f515b83dc2f4c |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-07 | 189 | 285 | 10 | 6e52cac679e0541ca5f2be316bdabdbc34da6e18 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.13e-07 | 189 | 285 | 10 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.33e-07 | 190 | 285 | 10 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.55e-07 | 191 | 285 | 10 | a05e9a7eb137d804570dd7d8905975d735738767 | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 4.55e-07 | 191 | 285 | 10 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.55e-07 | 191 | 285 | 10 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.55e-07 | 191 | 285 | 10 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.77e-07 | 192 | 285 | 10 | 0afb9dbe468e0be442c326e11c5fc0f699b32f23 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.77e-07 | 192 | 285 | 10 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | severe-Myeloid-Neutrophils_3|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.00e-07 | 193 | 285 | 10 | f4d43dfbf4115dd0f843ea5cf08049220342a047 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.25e-07 | 194 | 285 | 10 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 5.25e-07 | 194 | 285 | 10 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | severe-Myeloid-Neutrophils_3|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.25e-07 | 194 | 285 | 10 | 1f8edab1c8ba48bc0114429ea47aab378b5830b7 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.50e-07 | 195 | 285 | 10 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.50e-07 | 195 | 285 | 10 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.50e-07 | 195 | 285 | 10 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | severe-Classical_Monocyte|World / disease stage, cell group and cell class | 5.50e-07 | 195 | 285 | 10 | cf638aac4d57ae0774008920a1a5e9dfd8c73885 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 5.50e-07 | 195 | 285 | 10 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | LRRK2 TENM2 PTPRD CNTN5 SCN2A FAT3 NTNG1 PLXNA4 KCNIP4 EPB41L2 | 5.50e-07 | 195 | 285 | 10 | 787e95fb59c40bba784544b662fac37606ae1427 |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.76e-07 | 196 | 285 | 10 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.76e-07 | 196 | 285 | 10 | 028a06ed92f1c058dcbeacd335625bf529e87a7b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | TANC2 LRRK2 MECOM FAT1 SCN2A SDK1 RALGPS2 GTF2IRD1 KCNIP4 PATJ | 6.04e-07 | 197 | 285 | 10 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd |
| Drug | Pregnenolone [145-13-1]; Up 200; 12.6uM; MCF7; HT_HG-U133A | TANC2 ITGA2 ZZEF1 NF1 KCNF1 CACNA1H RALGPS2 KYAT1 PCNX1 GREB1 ATM MAPK8 FCMR | 6.98e-07 | 187 | 284 | 13 | 2856_UP |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | TANC2 TRIO PSG1 SNX13 AP3D1 PSD3 ST3GAL4 SKP2 ARL4C CCDC88A STS SMARCC1 ATM | 6.98e-07 | 187 | 284 | 13 | 4323_DN |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | IL18 ZZEF1 NF1 STIP1 NOS1 SRSF5 PSD3 TDRD1 ARL4C LRIG1 CD22 SENP6 | 5.37e-06 | 191 | 284 | 12 | 5953_UP |
| Drug | Nicardipine hydrochloride [54527-84-3]; Up 200; 7.8uM; MCF7; HT_HG-U133A | CDK19 NEB SNX13 NF1 CLCA1 SPON2 BAIAP3 FKBP10 ST3GAL4 OMG TENM3 CD22 | 7.75e-06 | 198 | 284 | 12 | 3215_UP |
| Drug | Talampicillin hydrochloride [39878-70-1]; Up 200; 7.8uM; MCF7; HT_HG-U133A | ZZEF1 SVEP1 PHEX OR7A10 COL6A1 PSD3 NUP214 PDE12 CD22 SLCO2A1 ATM FCMR | 7.75e-06 | 198 | 284 | 12 | 3515_UP |
| Drug | Pinacidil [85371-64-8]; Up 200; 16.4uM; PC3; HT_HG-U133A | TRIO CDK19 MECOM NEB ZZEF1 SNX13 NF1 FKBP10 REXO5 ST3GAL4 PREX2 MAPK8 | 7.75e-06 | 198 | 284 | 12 | 6356_UP |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Down 200; 6uM; MCF7; HT_HG-U133A | CDK19 PDZD8 SRSF5 RALGPS2 PHTF2 PCDHA6 TDRD1 SKP2 SAR1A IGF2R NETO2 | 1.06e-05 | 171 | 284 | 11 | 5247_DN |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | TANC2 TRIO CDK19 MECOM ERBIN NF1 KIF11 DOCK9 GTF2IRD1 NCAPH KIF20B | 1.25e-05 | 174 | 284 | 11 | 7530_DN |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | IRX5 ERBIN SAFB ZC3H4 PHIP SCAF8 GTF2IRD1 NETO2 CD58 SENP6 GREB1 | 1.55e-05 | 178 | 284 | 11 | 1112_DN |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Down 200; 6uM; MCF7; HT_HG-U133A | CDK19 ITGA2 ARAP1 E2F3 ERN2 SKP2 SAR1A ARL4C NETO2 GREB1 PATJ | 1.72e-05 | 180 | 284 | 11 | 3290_DN |
| Drug | Hexetidine [141-94-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | ABCA12 TMEM94 NF1 SPON2 PSD3 PCDHA6 PREX2 ARL4C GREB1 ATM PATJ | 3.12e-05 | 192 | 284 | 11 | 3318_DN |
| Drug | Skimmianine [83-95-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | TRIO NEB PHEX NF1 CLCA1 CNTN5 BAIAP3 BEGAIN COL6A1 PSD3 OSBPL3 | 3.44e-05 | 194 | 284 | 11 | 6066_UP |
| Drug | Quinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | CNN2 RHBDF2 DOCK9 ST3GAL4 CCDC88A PDE12 STS PCNX1 ATM PATJ FCMR | 3.44e-05 | 194 | 284 | 11 | 4529_DN |
| Drug | Carbarsone [121-59-5]; Up 200; 15.4uM; PC3; HT_HG-U133A | MYH2 NF1 SRSF5 PHTF2 ST3GAL4 HUWE1 THAP9 OMG PREX2 STS LRIG1 | 3.60e-05 | 195 | 284 | 11 | 3991_UP |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A | ABL2 ABCA12 TRAIP CACNA1H PCDHA6 NUP214 ERN2 ARL4D PCNX1 GREB1 MAST3 | 3.60e-05 | 195 | 284 | 11 | 2278_DN |
| Drug | p-difluorobenzene | 3.74e-05 | 6 | 284 | 3 | CID000010892 | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; MCF7; HT_HG-U133A | PHEX SAFB NF1 CACNA1H RALGPS2 ST3GAL4 ERN2 STS SMARCA4 PCNX1 ATM | 3.77e-05 | 196 | 284 | 11 | 3333_DN |
| Drug | Acetazolamide [59-66-5]; Up 200; 18uM; MCF7; HT_HG-U133A | TRIO PHEX NF1 NOS1 FKBP10 COL6A1 PHTF2 TMEM43 STS SLCO2A1 MAPK8 | 3.77e-05 | 196 | 284 | 11 | 1686_UP |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A | PSKH1 HSD17B1 ARAP1 COL6A1 ERN2 NCAPH ARL4C SENP6 SMARCC1 PATJ EPB41L2 | 3.77e-05 | 196 | 284 | 11 | 5523_DN |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; PC3; HT_HG-U133A | TANC2 PLXND1 NF1 PLA1A MMP2 ARAP1 ST3GAL4 ARL4C OSBPL3 ACSL5 FCMR | 3.77e-05 | 196 | 284 | 11 | 4467_DN |
| Drug | Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A | ABL2 NF1 CACNA1H CNN2 SEC23A ARAP1 FKBP10 DOCK9 PHTF2 PCDHA6 ERN2 | 3.77e-05 | 196 | 284 | 11 | 2288_DN |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; HL60; HT_HG-U133A | TRAIP SNX13 AP3D1 ARAP1 RHBDF2 PSD3 ERN2 SKP2 PDE12 MAST3 FCMR | 3.77e-05 | 196 | 284 | 11 | 2969_UP |
| Drug | methylated derivative | 3.83e-05 | 16 | 284 | 4 | CID006475710 | |
| Drug | Epivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | TRIO TRAIP FKBP10 TPST1 RALGPS2 PHTF2 ST3GAL4 KYAT1 STS PCNX1 ATM | 4.14e-05 | 198 | 284 | 11 | 6838_DN |
| Drug | Sotalol hydrochloride [959-24-0]; Up 200; 13uM; PC3; HT_HG-U133A | PHEX NF1 SCN2A FKBP10 SRSF5 PHTF2 NTNG1 TDRD1 SKP2 PDE12 DCAF11 | 4.14e-05 | 198 | 284 | 11 | 4079_UP |
| Drug | Metformin hydrochloride [1115-70-4]; Up 200; 24.2uM; MCF7; HT_HG-U133A | TANC2 SVEP1 PHEX NF1 C1orf159 GNA11 MMP2 BAIAP3 FKBP10 ERN2 KYAT1 | 4.14e-05 | 198 | 284 | 11 | 1694_UP |
| Drug | nifedipine; Down 200; 10uM; MCF7; HG-U133A | ABL2 TRIO SAFB SPON2 COL6A1 ERN2 SKP2 KIF20B SLC28A1 ACSL5 FCMR | 4.33e-05 | 199 | 284 | 11 | 603_DN |
| Drug | Nitrofural [59-87-0]; Up 200; 20.2uM; MCF7; HT_HG-U133A | TRIO ZZEF1 NTN1 BAIAP3 COL6A1 RALGPS2 PDE12 SLCO2A1 IRAK3 ATM MAPK8 | 4.33e-05 | 199 | 284 | 11 | 3320_UP |
| Drug | Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A | LARP6 PHEX AIPL1 ERN2 LGR5 TDRD1 ARL4D ARL4C CCDC88A PATJ MAST3 | 4.54e-05 | 200 | 284 | 11 | 3425_UP |
| Disease | Colorectal Neoplasms | BOC ABCC4 ABCA12 FAT1 PTPRD FEN1 MMP2 NTNG1 LGR5 SLCO2A1 ABCB11 EIF3H BOLL | 2.61e-06 | 277 | 278 | 13 | C0009404 |
| Disease | colorectal cancer | BOC ABCC4 POP4 ABCA12 PTPRD CNTN5 FEN1 MMP2 NOS1 SDK2 UBA2 ZAP70 LRIG1 OSBPL3 SLCO2A1 KCNIP4 PCNX1 EIF3H PDZD2 | 5.43e-06 | 604 | 278 | 19 | MONDO_0005575 |
| Disease | Colorectal Carcinoma | BOC ABCC4 ABCA12 FAT1 NF1 PTPRD PDILT FEN1 MMP2 DNAH8 WDR49 PHIP NTNG1 LGR5 PREX2 SLCO2A1 ABCB11 EIF3H BOLL ACSL5 | 1.31e-05 | 702 | 278 | 20 | C0009402 |
| Disease | lung non-small cell carcinoma (is_marker_for) | 3.45e-05 | 169 | 278 | 9 | DOID:3908 (is_marker_for) | |
| Disease | Congenital Heart Defects | 5.76e-05 | 44 | 278 | 5 | C0018798 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 7.18e-05 | 74 | 278 | 6 | DOID:3748 (is_marker_for) | |
| Disease | craniolenticulosutural dysplasia (implicated_via_orthology) | 8.84e-05 | 2 | 278 | 2 | DOID:0070307 (implicated_via_orthology) | |
| Disease | Phakomatosis cesioflammea | 8.84e-05 | 2 | 278 | 2 | C3838883 | |
| Disease | Congenital hemangioma | 8.84e-05 | 2 | 278 | 2 | C0235753 | |
| Disease | congenital dyserythropoietic anemia type II (implicated_via_orthology) | 8.84e-05 | 2 | 278 | 2 | DOID:0111401 (implicated_via_orthology) | |
| Disease | Port-wine stain with oculocutaneous melanosis | 8.84e-05 | 2 | 278 | 2 | C1274879 | |
| Disease | Intellectual Disability | TANC2 FRMPD4 TRIO TMEM94 CSDE1 NF1 UGP2 TAF6 TET3 PHIP DYNC1H1 E2F3 CHD8 RNASET2 | 9.90e-05 | 447 | 278 | 14 | C3714756 |
| Disease | severe acute respiratory syndrome, COVID-19 | FRMPD4 RPN1 LRP1B TENM2 PTPRD PDILT GNAQ PSD3 PCDHA6 PREX2 GCNT7 KCNIP4 PATJ PDZD2 | 9.90e-05 | 447 | 278 | 14 | EFO_0000694, MONDO_0100096 |
| Disease | epilepsy (implicated_via_orthology) | 1.66e-04 | 163 | 278 | 8 | DOID:1826 (implicated_via_orthology) | |
| Disease | age at menarche | LRP1B TENM2 GAB2 RPS6KC1 PTPRD ZC3H4 CNTN5 SCN2A PDILT GNAQ BEGAIN EEFSEC ZBTB46 SENP6 GREB1 MAST3 | 1.83e-04 | 594 | 278 | 16 | EFO_0004703 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TYADLGKSARDVFTK | 6 | P21796 | |
| SGRKLAELQASLSKY | 516 | Q9BXT4 | |
| VRTGLDLKANKTFAY | 51 | O60507 | |
| LLGFLQASRKYSEFT | 11 | Q9BZS9 | |
| LDTANKKVFLGRDTY | 126 | P08243 | |
| TVIYKNKGSSFLERE | 261 | P0C875 | |
| DGKNIVRSKSATLLY | 906 | Q96RT1 | |
| YRAILEKNFSFLSKG | 1061 | Q9HCK8 | |
| KTAQGSLSLKAYRLT | 156 | O15372 | |
| NRLFKLGRYEEASSK | 186 | Q9NZN9 | |
| LDSAGKTTVLYRLKF | 21 | P56559 | |
| SAGKTSLLYRLKFKE | 31 | P49703 | |
| KDFRRTTYANSSLIK | 281 | Q9BWU1 | |
| KKYELTGNFSSVASL | 681 | P42684 | |
| TVRYGKFLSLLKDGA | 1016 | Q96NH3 | |
| YFKQIVKSARANGTA | 321 | O94812 | |
| LSRKDSLTKAQLYGT | 576 | Q9BUH8 | |
| TTQGFRVIALAYKKL | 651 | Q4VNC1 | |
| STIRFKKSFLRNGSY | 401 | Q86UK0 | |
| REAKRLYKSNELFGS | 941 | Q86UK0 | |
| ESDLRKFFSQYGSVK | 46 | Q8N9W6 | |
| SYGVRSIAEFLAKSK | 146 | Q6PIY5 | |
| RSVKFNKGYTALSQS | 101 | Q5XKK7 | |
| TTIVKRYSKNGRIFF | 161 | P28676 | |
| DYGLTAAVFTKNLDK | 436 | P47895 | |
| LDGKSSLLYRFDQKS | 186 | Q9C0A0 | |
| QGYAFAKSGELLTKR | 816 | O95342 | |
| LAYRSVKSGLQEAAK | 1371 | Q9UKA4 | |
| KSFGSLRNIYKAEEN | 861 | Q99490 | |
| FKGTRYLNKSFVLGS | 396 | Q9NU02 | |
| SKRLLGYVATLKDNF | 516 | O75534 | |
| TQDGRKIYFTDSSSK | 206 | Q9HDC9 | |
| DSSVKRGYFQKSLVL | 141 | Q8NEG7 | |
| KGTVTYRSKFLQSDT | 116 | Q9BYV7 | |
| NKFYSLNSTTGKIRT | 821 | Q9H251 | |
| SKFTFKRIGYLAASQ | 86 | O14617 | |
| AVYNKGTSLAEKLLS | 141 | Q9H560 | |
| GLSTSYAALLRIKKS | 26 | O94779 | |
| LSRSKRTGNSKGYAF | 76 | Q9BYG3 | |
| TYTKNFRLSQDDIKG | 426 | P08253 | |
| LSLGKKFEVTYVSLQ | 136 | O95631 | |
| GKSSLALRYVKNDFK | 31 | Q9H0T7 | |
| AGLTKLTTRKDNYNA | 116 | Q96QF0 | |
| FSSQKAYKIVLAGDA | 536 | Q8IZ41 | |
| TLFEGKRVSFYKRAQ | 196 | Q5T6V5 | |
| RKGEASDNKLYTVFN | 236 | Q52LD8 | |
| LKNEGGFTRKYSLSS | 221 | Q8HWS3 | |
| YRKNATRDATATLKA | 116 | P78411 | |
| DKRGFTKLVYQNIFT | 71 | P50148 | |
| KLSSSEYFGLDVKIN | 171 | Q9UN73 | |
| SIKAIASIAEKYFGS | 661 | Q03112 | |
| TKFLSYKFSNSGSRI | 81 | P14555 | |
| ELSYKTNGLALSKRF | 276 | A5PLL1 | |
| KNFRFSSLAKDELGY | 336 | Q96NW4 | |
| LYARTTGKLKTDNVF | 241 | Q5VWQ8 | |
| RYKIVSGDSENLFKA | 71 | Q14517 | |
| VGDRKNYASAKLSEL | 211 | Q9Y2X3 | |
| AAFLESTFLKYRGTQ | 486 | Q9NSY0 | |
| RKISTDGSNYTLLKQ | 3026 | Q9NZR2 | |
| SFKNRVYLDTVSGSL | 76 | P19256 | |
| KIRSVEGSQLKAYLS | 126 | Q96JA1 | |
| LKKGSQVEALFSYEA | 456 | P19878 | |
| KTQLAYFTDSKNTGR | 911 | Q3T906 | |
| YFTDSKNTGRQLKDT | 916 | Q3T906 | |
| RYVNKILNSKFGFTS | 936 | Q3T906 | |
| NKKYFGLSEFIESTL | 851 | Q4ZG55 | |
| SDVKYKSDLNLTRGV | 1651 | Q86VF7 | |
| FKISSSYSGRVLKQV | 21 | A6NFK2 | |
| FILKGLRKSSEYSRN | 361 | Q96S38 | |
| SKSYLTLENGKVFLT | 101 | Q9UBS5 | |
| ERNGSSLAKIYTEAK | 61 | Q92522 | |
| YQILEKGAAKRTTAA | 211 | P52732 | |
| GTSKLYDIRKTIFTF | 506 | P46020 | |
| LQTDLRKFRSYKGTS | 831 | Q76MJ5 | |
| KATQTDIKLSRYTAG | 2586 | Q2LD37 | |
| RQFAIEYISKSGKTQ | 166 | Q8N3X6 | |
| AKYDIKALIGRGSFS | 96 | P11801 | |
| FKSRLVELLVSYGNT | 36 | P51572 | |
| LTDSYKFRAKDGSFV | 431 | Q8WYA1 | |
| FYRTRTLQALSSEKK | 56 | Q8N568 | |
| RGYSSLLKRDFGAKT | 516 | P17844 | |
| AKFLTLGSKFRYSGR | 506 | O43491 | |
| ASFKKTERLEVSYQG | 746 | Q3V6T2 | |
| IDKKLSFFCLAGYTT | 51 | P05160 | |
| RSATGAKSKYLIFTT | 341 | Q969U6 | |
| NLTATKFKLYGITFT | 1091 | Q96RV3 | |
| GAVNRIYKLSSDLKV | 66 | Q9HCM2 | |
| ASKEGKSRDRFSYVL | 966 | Q9Y4D7 | |
| KAIKSYARSNEFSLV | 301 | Q9NYQ8 | |
| GDSTFTVLKRYQNLK | 16 | P45983 | |
| ISYGYIAKAVLRTKS | 216 | Q9Y3N9 | |
| VSYTLEKNTKNGLTR | 196 | Q5SWX8 | |
| ALLYRQKSDGKIAAS | 21 | Q7Z5P9 | |
| RSLGTELFKIKNAYE | 1481 | Q9UKX2 | |
| GLATFYRKSKFSLLS | 381 | Q6L8Q7 | |
| TAIRKAEYSQGKSSL | 2176 | O15018 | |
| VFGKSAYLFVKLSRV | 211 | Q8NEN9 | |
| IDSKGDARYLISNSK | 361 | Q8TEB1 | |
| YGRKQSEDIISFIKS | 871 | Q96JB1 | |
| DTLRYSFNKLQSKAV | 1166 | Q96JB1 | |
| RLSQDVKGYSFIKDL | 301 | Q96Q89 | |
| GFLYAQNSTKRSIKE | 21 | Q6PIL6 | |
| FKYFIKSENGTRLVL | 196 | Q8WVF5 | |
| TYSERASKLFQGKNI | 46 | Q5S007 | |
| KKSNSISVGEFYRDA | 906 | Q5S007 | |
| KERSSLLAVSNKYGL | 36 | P35658 | |
| RNKLGYVSVKLLTSF | 121 | Q9BRS8 | |
| VSKYSGVFSFLLQLK | 1621 | Q96RT7 | |
| RALQKFTEAYGSLVL | 136 | Q9Y546 | |
| NASFGKKLRDDYLAS | 396 | Q8N159 | |
| RSYGEEKAVSFLKQT | 441 | O15553 | |
| EFRKKFGKSLYSSLQ | 311 | O76027 | |
| YKTSFGQLEVFREKS | 371 | Q9H0R1 | |
| IRQGKLSIKTDVYSF | 346 | Q9Y616 | |
| FSKRSNYITRLGSDK | 141 | Q7Z6Z7 | |
| SVTLKNKRESAYNTG | 826 | P17301 | |
| AYRKNATRDATATLK | 116 | Q9BZI1 | |
| KASSKLGENFYVRQD | 201 | Q8TCB7 | |
| TLQAKNKGVFRELYT | 1301 | P29475 | |
| TIDNSFLITGLKKYT | 661 | Q9UMZ3 | |
| VNSLFSKYKTGESLR | 6 | P17481 | |
| ILAKSKFYGNSLSAI | 536 | Q9BZF1 | |
| SGTLRSNILFGKKYE | 486 | O15439 | |
| KKDSGYVIALRSYIT | 1421 | Q96JP2 | |
| DFIRKTLNAGAYSKV | 161 | P50897 | |
| RKFYITQLKTDSEGA | 546 | Q4G163 | |
| QKGLSEYLETKRSAF | 1311 | Q9P2D7 | |
| RLSGKCFSLVESTYK | 66 | Q9UJJ9 | |
| KYSSGFRNIAVKENL | 331 | Q13315 | |
| SAIRENDIKSYFGRK | 16 | P39748 | |
| GKKFDSSYDRNTLVA | 76 | Q96AY3 | |
| SLYKKLGRILGNTFT | 121 | Q86XA9 | |
| YAELESRLNSSFKGK | 556 | A4D2P6 | |
| LEKGTSYKFRVRALN | 671 | Q9BWV1 | |
| KTRYDTSLGLLTKKF | 176 | O00716 | |
| RLLKLYSDKFGSENV | 1831 | Q9BZ29 | |
| FYREASSGAAKKRLL | 926 | P12109 | |
| ISSKTEKVAYAGFTR | 166 | Q6ZNI0 | |
| GTISFVQYKEALKTL | 81 | A6NFE3 | |
| YRAILEKNFSFLTKG | 711 | Q8TD26 | |
| TDAFKKIGNAYAVLS | 146 | Q8TBM8 | |
| LKVYLENGQTKSFRF | 206 | Q14CM0 | |
| FKVYATLRDLKTQGR | 31 | P14061 | |
| DKRGFTKLVYQNIFT | 71 | P29992 | |
| AERGKLYFTNLQSKE | 291 | Q5T3F8 | |
| RKQFTAGSYDILTIK | 1316 | Q8TDW7 | |
| LFSYVLQDRAAKGSL | 441 | Q9BSK4 | |
| VLSLGYATKYTARSK | 321 | Q92819 | |
| AKRGELSKYFRTQID | 661 | Q9ULC5 | |
| FDFTVLSKRGIKSRY | 141 | O95243 | |
| TILANAKYFDGDLSK | 166 | Q8TDQ7 | |
| LAKSGENLVTSRYFL | 226 | O60307 | |
| EYFQSVSFSGKRRKV | 291 | Q9NS73 | |
| SFVRNSAGKSSSYLK | 71 | Q69YH5 | |
| KSVQKSLYGERDIAS | 571 | Q69YH5 | |
| YDFGLRALKSVLVSA | 2086 | Q14204 | |
| GSFFLYSKLTVDKSR | 281 | P01859 | |
| GFFTKKYRQSLLDRT | 3391 | Q9NYC9 | |
| LLFNTRYAKAIGISE | 571 | Q9UHL9 | |
| YRKSKRGSSFLAGEA | 406 | Q9UKT8 | |
| DYFGKLESKLSVIRN | 36 | Q14116 | |
| KETVLSLKRYNLGSS | 61 | Q8IZY5 | |
| TFSGKLRRIVDSKYF | 781 | O95180 | |
| LSVAGFFYLKRSSKL | 161 | Q96HA4 | |
| GSFLSKDFDARKAYL | 141 | Q8TCE6 | |
| SKTNRTLFIFGVTKY | 196 | Q00888 | |
| FRALQKLSSGSYKIG | 526 | Q9UPN6 | |
| FTSYKLRLKATNDIG | 1546 | Q7Z5N4 | |
| SYKFRVKATNDIGDS | 1471 | Q58EX2 | |
| KSGKVTAYDLLSNRV | 556 | P54277 | |
| GRLIFDNLKKSIAYT | 776 | P20648 | |
| KVKNLASSDSRGYDL | 561 | B7ZC32 | |
| KNTSKFDGTRLYEST | 66 | P20273 | |
| KKYVNSGTVTLLSFA | 296 | Q9HCH3 | |
| SETNRTLFLLGVTKY | 196 | P11464 | |
| LTAFRKTYDKTVALG | 121 | Q15008 | |
| TLAALERGFSVKYSA | 656 | O75473 | |
| NGTYLELRKDLGFSK | 866 | Q9H4L5 | |
| EARFRTAKKLYGSTF | 456 | Q2NL67 | |
| RTFALYKNGSSEKRE | 1496 | P23468 | |
| KEKYSSAPNAVAFTR | 81 | Q86X27 | |
| KFVAASYDIRGNFLK | 331 | Q5HYA8 | |
| RSKNQGKFVSLFYTI | 266 | Q5TZ20 | |
| ASLYGQLDTTKKLRD | 241 | Q9Y2I2 | |
| NLSEFISRYKSSGFI | 786 | O60391 | |
| YESLKKFGRSFLSKN | 356 | Q8N807 | |
| KKSTGSVDYLALDFQ | 606 | Q9UQC2 | |
| KSFSLGDIYFKLFRA | 2146 | P11717 | |
| GKRQKLTTSDIDYAL | 61 | P49848 | |
| VTLLFGKTNSEKYLE | 46 | Q9Y5W8 | |
| LSEAYFRKTGKRSKA | 211 | Q9Y6N5 | |
| DERFVSKAGKSNYQL | 206 | Q9HCS7 | |
| LLRFVTLGSETSKKY | 681 | Q8N3S3 | |
| SFREKYFSGVTKRIA | 441 | Q7Z4G4 | |
| SFYLIFTNEGRALKT | 46 | Q9BTV4 | |
| LKSIDGAYTIRKAQL | 646 | P19320 | |
| SARALAKYSITFTGK | 36 | Q9BUD6 | |
| TFIKGYTRKAAALEA | 426 | P31948 | |
| KINSSAYRKAFESRL | 246 | Q9BRQ8 | |
| VKGALSVAASAYKAL | 886 | Q14596 | |
| ISDKTRFAYDGLKRQ | 286 | P28331 | |
| KYFLQTEDAKGTLSL | 476 | Q9H0K6 | |
| RAISSAQGKYKAFST | 226 | O76100 | |
| SETNRTLFLLGVTKY | 196 | Q9UQ74 | |
| GSYFLITDISDFKRK | 336 | Q16773 | |
| FFRGATELYRTGKKS | 271 | Q7LGA3 | |
| KLASRNVESYTKLGN | 176 | P04843 | |
| KYKDSSSGRQLSEVF | 1471 | P51532 | |
| ITFAKLLKDQGYSTA | 116 | P08842 | |
| YGSKFQLRSSERSAK | 196 | O95707 | |
| AESKASKLFGNYSRD | 51 | Q11206 | |
| GFSSVLQFLGLYKKS | 11 | Q9NR31 | |
| FDLIEKGYLVLKSSS | 661 | Q9HCD6 | |
| QVLDVKSYARLFSKS | 311 | Q9UBT2 | |
| SFYDRIKLLAGKDST | 901 | Q9NT68 | |
| NVKLRYLSSRTAGYK | 1066 | Q9NT68 | |
| VYDGSSSIENLKAKF | 241 | Q8NC67 | |
| RAISSAQGKYKAFST | 226 | O14581 | |
| ISQSYQKEGLKVFFR | 261 | Q6ZT89 | |
| KEALISQLTRGKLSY | 1296 | P13533 | |
| YSILESVSKAKFAAG | 2091 | Q4LDE5 | |
| LQNFGLRTDIYSKKT | 596 | Q92922 | |
| QYRTKETTFGATLSK | 306 | P23515 | |
| FASYGDLKNAIEKLS | 151 | Q13243 | |
| SYVFRGTKDLSAKQL | 186 | Q15436 | |
| SYVFRGTKDLTAKQI | 186 | Q15437 | |
| TTRATDLKNLFSKYG | 416 | Q15424 | |
| AGKKSFSAQEREYIR | 226 | Q14849 | |
| YFNDKFIGLRLKSVS | 511 | Q7L0J3 | |
| YRNFKSISKALVERG | 631 | P49748 | |
| GAALGKQYSLTRFKT | 406 | Q9H6R3 | |
| KQYSLTRFKTLFVAG | 411 | Q9H6R3 | |
| YKTASAGKLLQDRRA | 751 | Q96P48 | |
| LGYVRSQFLKLKTSV | 116 | Q9UJ71 | |
| FKVAAGTLDASTKIY | 151 | Q15003 | |
| EATGKRFYFKNVAIL | 66 | A8K7I4 | |
| QVTSYLTKKFAELRS | 356 | Q96KP4 | |
| LYCSEFSVGRKSAKL | 66 | Q6UXS0 | |
| SYGLSAEVKNRLLSK | 11 | Q99439 | |
| YFKSSLTTIEKRFGL | 51 | Q92959 | |
| SGYRKNLQKSDLSTL | 291 | Q13309 | |
| ALTLKDILNGTFSYK | 41 | Q12884 | |
| SEAKSNRRVYAKGET | 3171 | A4UGR9 | |
| TGVYFSAVKNVIKLS | 126 | Q53H76 | |
| DALNSQKKYFGRSLE | 126 | O00584 | |
| LRSLQKGTFDSKYGE | 316 | Q9H9Y2 | |
| KLGSSFTKVQDYLRR | 431 | Q16851 | |
| KLYSGAQTDGKFLLR | 176 | P43403 | |
| YSVIGRSLFKKETNI | 486 | P57772 | |
| YNKFGKISLLSTDLF | 116 | Q6ZN11 | |
| KVDFFRKLGYSSTEI | 51 | Q5D1E8 | |
| GRFTAQVDKSSKYIS | 81 | A0A0B4J271 | |
| LLKYFGAQSVRVLSD | 46 | Q96LT9 | |
| KGSTAARTFYLIKDI | 56 | O00541 | |
| IADTLFSRKLNGKYR | 146 | Q8WWQ0 | |
| ITALYASDLKASKIG | 736 | Q9H5L6 | |
| LDFKRKARSGSSSYS | 481 | Q03431 | |
| IYGLTVVLRKKFSAS | 306 | Q6PCB7 | |
| RRFDGYVSESATSKK | 461 | Q6PCB7 | |
| SGSDRKKVLDFYQRA | 726 | Q12767 | |
| QLYGKSRREAVSFLK | 611 | Q8NI35 | |
| SSLRNYFVKFKVGEE | 56 | Q96R05 | |
| FDDKYTLKLTFISGR | 166 | Q15005 | |
| NKILDYLTSFSGITK | 266 | Q96IC2 | |
| YGEVIKKSFSTFRSL | 601 | Q8IV35 | |
| VVSTTNFIKAEYKGR | 61 | O60667 | |
| KGKAISRFSATPALY | 96 | Q99250 | |
| GDLSKSTVLRNYKEA | 216 | P29144 | |
| SKSGLEKNSLIYELF | 476 | Q96K76 | |
| ALKTLSIFYQAGTSK | 1586 | P21359 | |
| FRILGSERKKTIANY | 351 | P78562 | |
| SGEFILKTYVRRNKS | 81 | Q9GZR1 | |
| YLSSRAAGYKSVLKI | 1006 | Q9P273 | |
| SKLYEEGSNKRLFNV | 56 | P25788 | |
| AKSLLIKSNEGSYGF | 591 | Q70Z35 | |
| FSKKLLSGDKYRFSA | 241 | P0CK96 | |
| LLGSASDYIQSVFKR | 466 | O43151 | |
| SGSKRKLSTFSAYLE | 281 | Q8N841 | |
| EQIRIFLSYTKAGSS | 236 | O00337 | |
| TKELNQYRRAKEGSS | 221 | Q9UPT8 | |
| VDYKNFSASSIAKIG | 71 | Q13061 | |
| KRGFKETAFLYAISS | 116 | O14904 | |
| VIFTNKSLGKRDLYD | 246 | Q8NF99 | |
| SLFSQYSGKTIVERL | 1011 | O43149 | |
| LKSLAYRNKGSFDEA | 391 | Q6PGP7 | |
| KASRDGNTVSYLKLV | 66 | O15482 | |
| GNTVSYLKLVSKADR | 71 | O15482 | |
| IRQAFYKGIKCTTSS | 331 | Q2M3X9 | |
| GFSSVLQFLGLYKKT | 11 | Q9Y6B6 | |
| ITFGTSDKYRKRALI | 791 | Q6PJF5 | |
| SQSVAKAKYEFLFGR | 21 | Q9NYI0 | |
| FLCLRFKKSTLGYSD | 116 | Q6YBV0 | |
| KNVLLGSSRYFKTLY | 46 | Q86UZ6 | |
| RLKLVNASVAFYKTS | 1006 | O75962 | |
| LKSGRVFIIKSYSED | 386 | Q9BYJ9 | |
| RKDLFSSRSKLQTVY | 226 | Q9BWF2 | |
| QTLTYALKRSFKELG | 311 | Q9H3M0 | |
| SFAKVLVRTYLGKDA | 241 | Q5VTT5 | |
| LYSDSFRKQIQGKAA | 6401 | P20929 | |
| YIDTVSGLSDKKFQR | 656 | Q14957 |